Market Cap : 2.14 B | Enterprise Value : 2.23 B | PE Ratio : | PB Ratio : 12.48 |
---|
NAS:SRNE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:SRNE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sorrento Therapeutics's enterprise value is $2,228.07 Mil. Sorrento Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $39.99 Mil. Therefore, Sorrento Therapeutics's EV-to-Revenue for today is 55.72.
During the past 13 years, the highest EV-to-Revenue of Sorrento Therapeutics was 6830.64. The lowest was 0.93. And the median was 55.57.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2021-04-17), Sorrento Therapeutics's stock price is $7.490000. Sorrento Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.17. Therefore, Sorrento Therapeutics's PS Ratio for today is 43.29.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
* The bar in red indicates where Sorrento Therapeutics's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Sorrento Therapeutics's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 2228.071 | / | 39.986 | |
= | 55.72 |
Sorrento Therapeutics's current Enterprise Value is $2,228.07 Mil.
Sorrento Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was 7.721 (Mar. 2020 ) + 9.007 (Jun. 2020 ) + 11.753 (Sep. 2020 ) + 11.505 (Dec. 2020 ) = $39.99 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Sorrento Therapeutics's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 7.490000 | / | 0.173 | |
= | 43.29 |
Sorrento Therapeutics's share price for today is $7.490000.
Sorrento Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.042 (Mar. 2020 ) + 0.042 (Jun. 2020 ) + 0.046 (Sep. 2020 ) + 0.043 (Dec. 2020 ) = $0.17.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
No Headline